Clinical Trials Directory

Trials / Completed

CompletedNCT02473419

Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
107 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of this research is to use functional magnetic resonance imaging (fMRI) with a neuropsychological task to test the prefrontal mechanism of action of the medical food Vayarin.

Detailed description

The investigators prior research suggests that effective non-stimulant treatments for ADHD act through key prefrontal regions that subserve inhibitory and executive functions, although different medications may achieve these effects via distinct mechanisms. The objective of this research is to use functional magnetic resonance imaging (fMRI) with a face go/no-go task to test the prefrontal mechanism of action of the medical food Vayarin. Participants are not treated at the Icahn School of Medicine, but instead will be recruited from trials of Vayarin that are enrolling and treating participants at New York University and The Medical Research Network.

Conditions

Interventions

TypeNameDescription
DRUGVayarin
DRUGPlacebo

Timeline

Start date
2015-05-01
Primary completion
2017-03-02
Completion
2017-03-02
First posted
2015-06-16
Last updated
2017-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02473419. Inclusion in this directory is not an endorsement.